AIG1 Antikörper (N-Term)
Kurzübersicht für AIG1 Antikörper (N-Term) (ABIN1450141)
Target
Alle AIG1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 17 amino acid synthetic peptide near the amino terminus of Human AIG1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- AIG1 (Androgen-Induced 1 (AIG1))
-
Andere Bezeichnung
- AIG1
-
Hintergrund
- Androgen-induced 1 (AIG1) is a novel Pirh2-interacting protein, which was initially cloned from human dermal papilla cells and is evolutionally conserved from drosophila through to humans. It is a membrane protein and belongs to the protein family containing FAR-17a domain. AIG1 may play a role in androgen-regulated growth of hair follicles. AIG1 could serve as a new biomarker for the diagnosis and prognostic evaluation of HCCs and may be a novel candidate tumor suppressor.Synonyms: Androgen-induced protein 1, CGI-103
-
Gen-ID
- 51390
-
NCBI Accession
- NP_057192
Target
-